Peripheral Neuropathy Trial, Recruiting NCT06243848 Sponsor: Afyonkarahisar Health Sciences University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06243848
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had tingling, numbness, or pain in the hand (in the area controlled by the median nerve) that occurs at night, with certain positions, or with movement, lasting for more than 3 months.
  • People whose carpal tunnel syndrome has been confirmed as mild, moderate, or severe through nerve conduction or electrical testing.
  • People who have numbness, reduced sensation, or weakness in the thumb-side muscles of the hand in the area controlled by the median nerve.
  • People who have had a positive result on either the Phalen test (a wrist-bending test) and/or the Tinel sign (a tapping test over the wrist) performed by a doctor.

Who may not be able to join:

  • People whose symptoms may be caused by a different condition, such as a pinched nerve in the neck, widespread nerve damage, nerve problems around the shoulder, or compression at the collarbone area.
  • People who have had an injection into the carpal tunnel area in the past 6 months.
  • People who have noticeable muscle wasting at the base of the thumb.
  • People who have previously had surgery for carpal tunnel syndrome.
  • People who regularly take anti-inflammatory medications (such as ibuprofen) or steroid medications.
  • People who are pregnant.
  • People who have been diagnosed with conditions such as rheumatoid arthritis, lupus, gout, systemic sclerosis, dermatomyositis, or polymyositis.
  • People who have been diagnosed with cancer.
  • People who currently have an active infection.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nuran EYVAZ, MD, Afyonkarahisar Health Sciences University

Phone: +905469347374

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Afyonkarahisar Health Sciences University
Registry
ClinicalTrials.gov
Start date
25 January 2024
Est. completion
24 April 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Change from baseline visual analog scale (VAS) wrist pain at 4th and 12th week

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov